Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018
- PMID: 32977435
- PMCID: PMC7579392
- DOI: 10.3390/ijerph17196943
Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018
Abstract
Introduction: In recent years, an increase in healthcare-associated infections (HAIs) caused by resistant pathogens, which is a clinically troublesome trend, has been observed. The aim of the study was to analyze the microbial factors of HAIs and the drug resistance of microorganisms to selected antibiotics and their consumption. Material and Methods: The retrospective study included 3708 patients hospitalized in the intensive care unit (ICU) of the University Teaching Hospital in Wroclaw, who were diagnosed with 742 HAIs in the period from 1 January 2011 to 31 December 2018. The aim of the study was the analysis of microorganisms isolated in the respective clinical forms of HAIs, including the occurrence of "alert pathogens", presence of multidrug-resistant (MDR) strains, and consumption of selected antibiotics. Findings: During the study period, 846 microorganisms were cultured in patients with HAIs, and among them, Acinetobacter baumannii MDR represented 31.8%; Klebsiella pneumoniae ESBLs, 11.3%; Pseudomonas aeruginosa MDR, 4.1% and MRSA, 2.2%; and Enterococcus spp. vancomycin-resistant enterococci (VRE), 1.3%. Among all the pathogens, Gram-negative bacteria (GNB) were dominant (71.6%). Gram-positive bacteria and fungi accounted for 21.6% and 7%, respectively. The total number of strains responsible for ventilator-associated pneumonia (VAP), urinary tract infection (UTI), and central line-associated blood stream infection (CLA-BSI) was as follows: 458 (54.1%), 274 (32.4%), and 114 (13.5%), respectively. Among the etiological factors of VAP, there was a prevalence of A. baumannii MDR (41.9%), as well as in the case of UTI (21.9%). With regards to CLA-BSI, MRCNS (29.8%) was the dominant pathogen. The "alert pathogens" accounted for 54.7% of all the analyzed strains. The MDR strains represented 72.6% and 9.7% among A. baumannii and P. aeruginosa, respectively. In the years 2011 vs. 2018, an increase in infections with MDR bacilli was observed, 34.6% vs. 61.0% (p = 0.0008), respectively, including A. baumannii MDR 16.54% vs. 34.56 % (p = 0.0009) and Enterobacterales ESBL+/AMPC 11.8% vs. 15.44 % (p = 0.3921). Resistance to methicillin was confirmed in 35.2% of S. aureus strains. Resistance to vancomycin was found among 30.9% of Enterococcus spp. The observed period was marked by an increase in the consumption of carbapenems: 197.7 vs. 235.9 defined daily dose (DDD)/1000 patients-days. Conclusions: Gram-negative bacteria were found to be dominant pathogens in healthcare-associated infections. The most frequently cultured pathogens were multidrug-resistant A. baumannii, K. pneumoniae ESBL(+), and P. aeruginosa. The study showed an increase in the incidence of "alert pathogens" and MDR bacilli, as well as the tendency of a growing resistance to antibiotics during the observed period. Microbiological analysis of HAIs and the consumption of antibiotics is the necessary element of the proper antibiotic policy in hospitals.
Keywords: DDD; healthcare-associated infections; intensive care unit; multidrug-resistant pathogens.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Device associated -health care associated infections monitoring, prevention and cost assessment at intensive care unit of University Hospital in Poland (2015-2017).BMC Infect Dis. 2020 Oct 16;20(1):761. doi: 10.1186/s12879-020-05482-w. BMC Infect Dis. 2020. PMID: 33066740 Free PMC article.
-
Pseudomonas aeruginosa device associated - healthcare associated infections and its multidrug resistance at intensive care unit of University Hospital: polish, 8.5-year, prospective, single-centre study.BMC Infect Dis. 2021 Feb 16;21(1):180. doi: 10.1186/s12879-021-05883-5. BMC Infect Dis. 2021. PMID: 33593280 Free PMC article.
-
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.Infect Control Hosp Epidemiol. 2008 Nov;29(11):996-1011. doi: 10.1086/591861. Infect Control Hosp Epidemiol. 2008. PMID: 18947320
-
The interface between COVID-19 and bacterial healthcare-associated infections.Clin Microbiol Infect. 2021 Dec;27(12):1772-1776. doi: 10.1016/j.cmi.2021.06.001. Epub 2021 Jun 7. Clin Microbiol Infect. 2021. PMID: 34111586 Free PMC article. Review.
-
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.
Cited by
-
The immune responses to different Uropathogens call individual interventions for bladder infection.Front Immunol. 2022 Aug 23;13:953354. doi: 10.3389/fimmu.2022.953354. eCollection 2022. Front Immunol. 2022. PMID: 36081496 Free PMC article. Review.
-
Unpacking the Complexity of COVID-19 Fatalities: Adverse Events as Contributing Factors-A Single-Center, Retrospective Analysis of the First Two Years of the Pandemic.Viruses. 2023 Jun 24;15(7):1430. doi: 10.3390/v15071430. Viruses. 2023. PMID: 37515118 Free PMC article.
-
High prevalence of carbapenem-resistant Pseudomonas aeruginosa and identification of a novel VIM-type metallo-β-lactamase, VIM-92, in clinical isolates from northern China.Front Microbiol. 2025 Feb 26;16:1543509. doi: 10.3389/fmicb.2025.1543509. eCollection 2025. Front Microbiol. 2025. PMID: 40078538 Free PMC article.
-
The Resistome of ESKAPEE Pathogens in Untreated and Treated Wastewater: A Polish Case Study.Biomolecules. 2022 Aug 21;12(8):1160. doi: 10.3390/biom12081160. Biomolecules. 2022. PMID: 36009054 Free PMC article.
-
Monitoring of antimicrobial resistance in respiratory tract pathogens during the COVID-19 pandemic: A retrospective study.Medicine (Baltimore). 2024 May 10;103(19):e38101. doi: 10.1097/MD.0000000000038101. Medicine (Baltimore). 2024. PMID: 38728506 Free PMC article.
References
-
- Vincent J.-L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., Wolff M., Spencer R.C., Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995;274:639–644. doi: 10.1001/jama.1995.03530080055041. - DOI - PubMed
-
- Dudeck M.A., Weiner L.M., Allen-Bridson K., Malpiedi P.J., Peterson K.D., Pollock D.A., Sievert D.M., Edwards J.R. National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module. Am. J. Infect. Control. 2013;41:1148–1166. doi: 10.1016/j.ajic.2013.09.002. - DOI - PMC - PubMed
-
- Kübler A., Duszynska W., Rosenthal V.D., Fleischer M., Kaiser T., Szewczyk E., Barteczko-Grajek B. Device-associated infection rates and extra length of stay in an intensive care unit of a university hospital in Wroclaw, Poland: International Nosocomial Infection Control Consortium’s (INICC) findings. J. Crit. Care. 2012;27:105.e5–105.e10. doi: 10.1016/j.jcrc.2011.05.018. - DOI - PubMed
-
- Vincent J.-L., Sakr Y., Singer M., Martin-Loeches I., Machado F.R., Marshall J.C., Finfer S., Pelosi P., Brazzi L., Aditianingsih D., et al. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA. 2020;24:1478–1487. doi: 10.1001/jama.2020.2717. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous